Cynata Files New Patent Application for Cymerus Stem Cell Technology in Oncology
Australian stem cell and regenerative medicine company, Cynata Therapeutics Limited, announced today that the Company has filed a new patent application with IP Australia for oncology-related therapeutic uses of its proprietary Cymerus mesenchymal stem cell (MSC) technology. Highlights: • Application filed with IP Australia would expand patent estate to immunotherapy. • Creates new opportunities [...]